Joykem ODT 200 Tablet contains Amisulpride 200 mg, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and other psychotic disorders. Amisulpride exerts its therapeutic effect by selectively antagonizing dopamine D2 and D3 receptors in the central nervous system, thereby modulating dopaminergic neurotransmission implicated in psychotic symptoms. Joykem ODT 200 is formulated as an orally disintegrating tablet, facilitating rapid disintegration and absorption, which enhances patient compliance, especially in individuals with swallowing difficulties. The medication is effective in managing both positive symptoms, such as hallucinations and delusions, and negative symptoms, including social withdrawal and apathy. It is typically administered once or twice daily, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include extrapyramidal symptoms, insomnia, weight gain, and hyperprolactinemia; therefore, regular monitoring of neurological status and metabolic parameters is recommended. Caution is advised in patients with a history of cardiac arrhythmias or QT prolongation. Joykem ODT 200 should be prescribed and used under strict medical supervision, considering potential drug interactions and contraindications. This formulation offers an effective and convenient option for managing schizophrenia, improving adherence and overall treatment outcomes.